Diisopropylethylamine → 1-(4-Ethyl-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-4-(1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)butan-1-one
反応式
C(N(C(C)C)C(C)C)C.O.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC.Cl.[CH2:34]([CH:36]1[C:41]2[CH:42]=[CH:43][S:44][C:40]=2[CH2:39][CH2:38][NH:37]1)[CH3:35].[CH3:45][O:46][C:47]1[CH:52]=[C:51]([CH3:53])[C:50]([S:54]([N:57]2[CH2:62][CH2:61][CH2:60][CH2:59][CH:58]2[CH2:63][CH2:64][CH2:65][C:66](O)=[O:67])(=[O:56])=[O:55])=[C:49]([CH3:69])[CH:48]=1>C(=O)(O)[O-].[Na+]>[CH2:34]([CH:36]1[C:41]2[CH:42]=[CH:43][S:44][C:40]=2[CH2:39][CH2:38][N:37]1[C:66](=[O:67])[CH2:65][CH2:64][CH2:63][CH:58]1[CH2:59][CH2:60][CH2:61][CH2:62][N:57]1[S:54]([C:50]1[C:51]([CH3:53])=[CH:52][C:47]([O:46][CH3:45])=[CH:48][C:49]=1[CH3:69])(=[O:56])=[O:55])[CH3:35]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
N-Ethyldiisopropylamine (0.21 ml, 1.218 mmol), 1-hydroxybenzotriazole hydrate (60 mg, 0.447 mol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (116 mg, 0.609 mmol) and 4-ethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (123 mg, 0.609 mmol) were added to a solution of 4-(1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)butanoic acid (AC7) (0.15 g, 0.406 mmol) in MC (10 ml) and the mixture was stirred at room temperature for 15 hours. Saturated sodium bicarbonate solution (20 ml) was added to the mixture and the aqueous phase was then extracted with MC (2×30 ml). The combined organic phases were dried (MgSO4) and concentrated in vacuo. The crude product was purified by column chromatography (silica gel) with hexane/ethyl acetate 2/1. The yield was 200 mg (94%, white, resin).
後処理
- extractionthe aqueous phase was then extracted with MC (2×30 ml)
- dry with materialThe combined organic phases were dried (MgSO4)
- concentrationconcentrated in vacuo
- customThe crude product was purified by column chromatography (silica gel) with hexane/ethyl acetate 2/1
出典と根拠
- ORDレコード
- ord-3fca1cf5818241bdaa791cc11ae3ba63
- 出典データセット
- uspto-grants-2012_09
- 特許番号
- US08268814B2
反応ノート
読み込み中…